1. Assessing the serum concentration levels of NT-4/5, GPX-1, TNF-α, and l -arginine as biomediators of depression severity in first depressive episode patients with and without posttraumatic stress disorder
- Author
-
Adam R. Szromek, Ewa Ogłodek, Aleksander Araszkiewicz, and Marek J. Just
- Subjects
Adult ,Male ,medicine.medical_specialty ,GPX1 ,Arginine ,Receptors, Nerve Growth Factor ,behavioral disciplines and activities ,Gastroenterology ,Stress Disorders, Post-Traumatic ,Young Adult ,03 medical and health sciences ,Sex Factors ,Glutathione Peroxidase GPX1 ,0302 clinical medicine ,Pharmacotherapy ,Internal medicine ,mental disorders ,medicine ,Humans ,Depression (differential diagnoses) ,computer.programming_language ,Pharmacology ,Glutathione Peroxidase ,Depression ,Tumor Necrosis Factor-alpha ,sed ,General Medicine ,Middle Aged ,Serum concentration ,030227 psychiatry ,Posttraumatic stress ,Female ,Tumor necrosis factor alpha ,Psychology ,computer ,Biomarkers ,030217 neurology & neurosurgery ,Clinical psychology - Abstract
Background Neurotrophin-4/5 (NT-4/5) and glutathione peroxidase-1 (GPX-1) have been shown to play a major role in neuronal processes including depression and posttraumatic stress disorder (PTSD). They protect the body from oxidative damage by affecting neuronal growth, development and plasticity. The aim of the study was to evaluate the concentrations of NT-4/5, GPX-1, tumor necrosis factor-α (TNF-α), and l -arginine in patients suffering from varying levels of depression severity, PTSD, and depression comorbid with PTSD. Methods The study involved 460 participants, 360 of whom were diagnosed with different types of depressive episodes. They included: 60 patients with mild depression (MD), 60 patients with moderate depression (MOD), 60 patients with severe depression (SeD), 60 patients with MD and PTSD (MD + PTSD), 60 patients with MOD and PTSD (MOD + PTSD), 60 patients with SeD and PTSD (SeD + PTSD), and 60 patients with PTSD alone. Each group of 60 subjects comprised 30 females and 30 males. The control group comprised 40 subjects. The 10th revision of the International Statistical Classification of Diseases and Related Health Problems was utilized to diagnose depression and PTSD. At 7 a.m. blood samples were collected and serum NT-4/5, GPX-1, TNF-α and l -arginine concentrations were assessed using the ELISA method. Results Depressive episodes with and without PTSD and PTSD alone became more severe as the levels of TNF-α, l -arginine increased and the levels of NT-4/5, GPX-1 decreased. Conclusion l -arginine, TNF-α, NT-4/5 and GPX-1 can be markers of depression severity in both males and females with first depressive episode with or without posttraumatic stress disorder.
- Published
- 2017